Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 138 results for "sarabjit kour nangra"

Buy Infosys with target price of Rs 4245: Angel Broking

Sarabjit Kour Nangra of Angel Broking shares her outlook on the road ahead for Infosys. Money Control, 2 weeks ago
Infosys: How analysts read Q1 numbers MyIris, 2 weeks ago

2 images for "sarabjit kour nangra"

Business Standard India, 2 months ago
Business Standard India, 3 months ago

Nexium generic next big opportunity for Ranbaxy: Angel

Sarabjit Kour Nangra VP Research- Pharma Angel Broking W The Nexium Generic is a bigger opportunity for Ranbaxy than Valcyte generic, she says in an interview with CNBC-TV18's Ekta Batra. Given the Sun-Ranbaxy merger, Nangra sees an upside ...
 Moneycontrol.com4 weeks ago Launch of generic diovan key opportunities for Ranbaxy: Angel Broking  MyIris4 weeks ago
The Week

Wipro Q1 profit rises 29% to Rs 2,118 crore

Wipro, India's third-biggest IT services exporter, reported 29 per cent growth in June quarter profit at Rs 2,118 crore compared with Rs 1,631 crore posted for the corresponding quarter last year. Total revenue stood at Rs 11,135 crore against Rs ...
 Financial Chronicle1 day ago UPDATE 2-India's Wipro sees strong sales growth, eyes Europe deals  Reuters1 day ago Wipro sees strong sales growth, eyes Europe deals  The Week23 hours ago India's Wipro sees strong sales growth, eyes Europe deals  Sharenet1 day ago

Ipca halts shipments from Ratlam unit after FDA flags violations

Ipca Laboratories said it has voluntarily stopped shipments to the US from its bulk drug manufacturing facility at Ratlam, Madhya Pradesh, after the Food and Drug Administration The letter outlined a half a dozen violations of standard production ...
 DNA India1 day ago After FDA concerns, Ipca halts drug shipment to US  Financial Chronicle1 day ago Angel Broking maintains 'Buy' on IPCA Lab  MyIris1 day ago Ipca stops US shipments of products from Ratlam facility  The Hindu1 day ago

TCS in milestone march

Mumbai, July 23: Tata Consultancy Services (TCS), India's largest software services player, today became the first domestic company to surpass Rs 5 lakh crore in market capitalisation. On a day when the key indices hit fresh records, the TCS scrip ...
 Calcutta Telegraph2 days ago

Angel Broking upgrades target price of Indoco Remedies to Rs 192

Indoco Remedies has received a nod from the USFDA for two of its facilities in Goa. The US health regulator has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna. Commenting on the same, Sarabjit Kour Nangra , VP ...
 Myiris3 days ago

Price caps on drugs hurt Indian units of global pharma firms

India capped prices of 50 diabetes and heart treatments last week, with limits possible for other medications too. Photo: Bloomberg Mumbai: India's widening of price controls to drugs with revenues of about $915 million adds pressure on the local ...
 Livemint.com6 days ago Price Caps on $915 Million of Drugs Hurt Sanofi: Corporate India  BusinessWeek1 week ago

TCS shares up nearly 3 pc on better-than-expected earnings

Shares of TCS today ended nearly 3 per cent higher after the country's largest software exporter posted better-than-expected earnings in the June quarter. Boosted by the smart earnings, TCS's shares settled 2.58 per cent higher at Rs 2,442.65 on ...
 Business Standard India1 week ago TCS shares surge over 4 p.c on positive results  The Hindu1 week ago

More drugs brought under price control

The National Pharmaceutical Pricing Authority (NPPA) has decided to fix the prices of 50 anti-diabetic and cardiac medicines. While the move will help consumers, it will erode the margins of pharmaceutical companies. The reduction will range from ...
 Hindu Business Line1 week ago Indian drug regulator puts price ceiling on 108 diabetes, cardiac formulations  VC Circle1 week ago Drug price reduction to impact Sanofi, Zydus Cadila, Ranbaxy most: Experts  MyIris1 week ago More drugs under NPPA coverage: Angel Broking  MyIris1 week ago

Pharma producers perturbed by expanded essential medicines list

The pharmaceutical industry, still coming to terms with the Drug Price Control Order (DPCO), 2013, which controls the prices of 652 drugs coming under the National List of Essential Medicines (NLEM), now has to deal with 108 more formulations, which ...
 The Hindu1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sarabjit kour nangra
Get updated on latest news & your favorite topics right in your inbox!
More     Less